글로벌 크로노박터 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 크로노박터 시장

크로노박터 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 4.60%의 CAGR로 성장할 것으로 분석합니다.

크로노박터는 건조한 곳에서 살 수 있는 박테리아의 한 종류로, 이전에는 엔테로박터 사카자키로 알려져 있었습니다. 이 세균은 분유, 허브차, 분유, 전분과 같은 건조 식품에서 발견되었습니다. 크로노박터 감염은 유아에게 드물고 생명을 위협하는 감염으로 뇌 주변 염증, 혈액 중독 및 장 감염을 일으킬 수 있습니다. 증상으로는 발작 , 발열, 복통, 구토, 황달 및 배변 시 혈액이 있습니다.

감염성 질환의 유병률 증가, 의료비 지출 증가, 치료 옵션 개발, 정부 자금 지원 증가, 질병에 대한 인식을 확산하기 위한 정부 및 민간 기관의 이니셔티브 증가는 크로노박터 시장을 확대할 요인입니다. 연구 개발 활동과 신흥 시장의 증가는 2021-2028년 예측 기간 동안 크로노박터 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료비, 약물과 관련된 부작용, 희귀 감염에 대한 인식 부족은 시장 성장을 방해하는 요인들이고, 위에서 언급한 예측 기간 동안 크로노박터 시장에 더 큰 어려움을 겪을 것입니다.

This cronobacter market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cronobacter market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cronobacter Market Scope and Market Size

The cronobacter market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the cronobacter market is segmented into antibiotic and others.
• On the basis of diagnosis, the cronobacter market is segmented into blood tests, laboratory tests and others.
• On the basis of dosage, the cronobacter market is segmented into tablet, injection and others.
• On the basis of route of administration, the cronobacter market is segmented into oral, intravenous and others.
• On the basis of end-users, the cronobacter market is segmented into clinic, hospital and others.
• The cronobacter market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Cronobacter Market Country Level Analysis

Cronobacter market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the cronobacter market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the cronobacter market due to the presence of major key players, growing investment for R&D activities, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Cronobacter market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Cronobacter Market Share Analysis

Cronobacter market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to cronobacter market research.

크로노박터 시장 보고서에서 다루는 주요 기업으로는 Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, Spero Therapeutics, Abbott, F. Hoffmann-La Roche Ltd., Mylan NV, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Cumberland Pharmaceuticals Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66168